Fundz

Vedantra Pharmaceuticals, Inc. reported raising $14.5 Million in an initial SEC Form D filing, from an offering of $14.5 Million

PRIVATEAug 03, 2018

Amount Raised

$14.5 Million

$14.5 Million sold, per SEC Form D (first sale Aug 3, 2018)

Round Type

Venture

BostonBiotechnology

Quick answer

Elicio Therapeutics raised $14.5 Million in a funding round, dated August 3, 2018. Elicio Therapeutics is based in Boston, Massachusetts, United States.

How much did Elicio Therapeutics raise?
Elicio Therapeutics raised $14.5 Million in a funding round on August 3, 2018.
What does Elicio Therapeutics do?
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer.
Where is Elicio Therapeutics based and how big is it?
Elicio Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 42 employees.
Who are the decision-makers at Elicio Therapeutics?
Fundz holds 1 contact at Elicio Therapeutics, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Elicio Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Inscripta raised $1.1M (Seed) on September 17, 2018.
  • Euphrates Vascular, Inc. raised $590K (Seed) on September 17, 2018.
  • MARIZYME INC raised $15M on September 17, 2018.
  • Propanc Biopharma raised $158K (Pre-Seed) on September 17, 2018.
  • BiOWiSH Technologies raised $7.5M on September 14, 2018.
  • Artelo Biosciences raised $526K on September 14, 2018.

Who to call at Elicio Therapeutics, and when

A new round usually means Elicio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elicio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elicio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elicio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elicio Therapeutics

Location

ONE KENDALL SQUARE

Boston, Massachusetts, United States

About

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is engineering investigational Amphiphile (“AMP”) immunotherapies intended to precisely target and fully engage the lymph nodes, the site in our bodies where the immune response is orchestrated. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elicio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPeter D., Chief Scientific OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elicio Therapeutics's next move

See what Strategic adds

Elicio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.